These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 9817979

  • 21. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
    Ferrandina G, Macchia G, Legge F, Deodato F, Forni F, Digesù C, Carone V, Morganti AG, Scambia G.
    Oncology; 2008; 74(1-2):42-9. PubMed ID: 18544959
    [Abstract] [Full Text] [Related]

  • 22. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G, Würz H, Bolte A.
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [Abstract] [Full Text] [Related]

  • 23. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
    Rose PG, Baker S, Fournier L, Nelson BE, Hunter RE.
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907
    [Abstract] [Full Text] [Related]

  • 24. [Establishment and characterization of a new SCC antigen producing cell line (HCS-2) from a carcinoma of the uterine cervix].
    Morisawa T, Kuramoto H, Shimoda T, Sakamoto I, Kato Y, Hamano M.
    Hum Cell; 1988 Sep; 1(3):308-14. PubMed ID: 2979208
    [Abstract] [Full Text] [Related]

  • 25. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
    Micke O, Bruns F, Schäfer U, Prott FJ, Willich N.
    Anticancer Res; 2005 Sep; 25(3A):1663-6. PubMed ID: 16033078
    [Abstract] [Full Text] [Related]

  • 26. Squamous cell carcinoma antigen in cervical cancer.
    Borras G, Molina R, Xercavins J, Ballesta A, Iglesias X.
    Eur J Gynaecol Oncol; 1992 Sep; 13(5):414-8. PubMed ID: 1486921
    [Abstract] [Full Text] [Related]

  • 27. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1105-13. PubMed ID: 20932670
    [Abstract] [Full Text] [Related]

  • 28. [Immunomorphological identification of an antigen associated with squamous cell carcinoma of the cervix uteri].
    Ievleva ES, Ermoshina NV, Ageenko AI.
    Eksp Onkol; 1988 Nov 15; 10(5):33-5. PubMed ID: 3061778
    [Abstract] [Full Text] [Related]

  • 29. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
    Hsieh CY, Chang DY, Huang SC, Yen ML, Juang GT, Ouyang PC.
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug 15; 88(8):797-800. PubMed ID: 2592943
    [Abstract] [Full Text] [Related]

  • 30. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM, Wang PH, Yen MS, Lai CR, Ng HT, Yuan CC.
    Gynecol Oncol; 2000 Jan 15; 76(1):103-6. PubMed ID: 10620449
    [Abstract] [Full Text] [Related]

  • 31. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
    Esajas MD, Duk JM, de Bruijn HW, Aalders JG, Willemse PH, Sluiter W, Pras B, ten Hoor K, Hollema H, van der Zee AG.
    J Clin Oncol; 2001 Oct 01; 19(19):3960-6. PubMed ID: 11579117
    [Abstract] [Full Text] [Related]

  • 32. Prognostic value of squamous cell carcinoma antigen in patients with uterine cervical carcinoma.
    Bhatavdekar JM, Ghosh N, Shukla MK, Balar DB, Bhaduri A, Karelia NH, Shah NG, Trivedi SN.
    Tumori; 1988 Apr 30; 74(2):221-5. PubMed ID: 3368976
    [Abstract] [Full Text] [Related]

  • 33. Scatchard analysis of EGF receptor and effects of EGF on growth and TA-4 production of newly established uterine cervical cancer cell line (OMC-1).
    Ueda M, Ueki M, Yamada T, Okamoto Y, Maeda T, Sugimoto O, Otsuki Y.
    Hum Cell; 1989 Dec 30; 2(4):401-10. PubMed ID: 2486664
    [Abstract] [Full Text] [Related]

  • 34. A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma.
    Gadducci A, Ferdeghini M, Prontera C, Giordano P, Cristofani R, Bianchi R, Fioretti P.
    Eur J Gynaecol Oncol; 1990 Dec 30; 11(4):283-8. PubMed ID: 2245812
    [Abstract] [Full Text] [Related]

  • 35. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
    Scambia G, Benedetti Panici P, Foti E, Amoroso M, Salerno G, Ferrandina G, Battaglia F, Greggi S, De Gaetano A, Puglia G.
    J Clin Oncol; 1994 Nov 30; 12(11):2309-16. PubMed ID: 7964945
    [Abstract] [Full Text] [Related]

  • 36. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A, Wojcieszek A, Mrochem J, Walaszek-Gruszka A, Deja R, Masłyk B, Bartnik W, Sodowski K.
    Ginekol Pol; 2009 May 30; 80(5):361-6. PubMed ID: 19548456
    [Abstract] [Full Text] [Related]

  • 37. [Squamous cell carcinoma (SCC)--nature and usage in patients with cervical carcinoma].
    Bocheva Y, Bochev P, Chaushev B, Ivanov S.
    Akush Ginekol (Sofiia); 2015 May 30; 54(2):29-34. PubMed ID: 25909138
    [Abstract] [Full Text] [Related]

  • 38. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C, Sliutz G, Mustafa G, Bieglmayr C, Koelbl H, Reinthaller A, Gitsch G.
    Gynecol Oncol; 1995 Mar 30; 56(3):402-5. PubMed ID: 7535720
    [Abstract] [Full Text] [Related]

  • 39. Detection of squamous-cell carcinoma antigen-expressing tumour cells in blood by reverse transcriptase-polymerase chain reaction in cancer of the uterine cervix.
    Stenman J, Lintula S, Hotakainen K, Vartiainen J, Lehväslaiho H, Stenman UH.
    Int J Cancer; 1997 Feb 20; 74(1):75-80. PubMed ID: 9036873
    [Abstract] [Full Text] [Related]

  • 40. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
    Ohno T, Nakayama Y, Nakamoto S, Kato S, Imai R, Nonaka T, Ishikawa H, Harashima K, Suzuki Y.
    Cancer; 2003 Jun 15; 97(12):3114-20. PubMed ID: 12784349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.